Surrogate markers for neurodegeneration (N) at the onset of Alzheimer’s disease are atrophy of the mesial temporal lobe, in particular the hippocampal formation, and an increase of total Tau in cerebrospinal fluid (CSF; Jack et al., 2018a). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.